Pioneering Market Access Strategies for Biopharma Success
Areas of Expertise
01
Oncology
A core of innovation experiencing an expansion of cell therapies and other novel mechanisms of action, combined with increasing complexity from intermediaries
02
Cardiology and Metabolic
An opportunity to bend the long-term cost curve but with significant challenges to actuarial models and free-rider economic problems
03
Rare Diseases
Gene therapies offer the promise of durable responses or even cures but mechanisms to pay for these breakthroughs can benefit from creative financing
04
Inflammation and Respiratory
Substantial improvements in meeting unmet needs for patients that benefit from deep understanding of health economic value of better controlling chronic disease
05
Digital Therapeutics
Prescription (PDT) and non-prescription (DTx) digital medicines may treat more patients, improve access and equity, and at cost-saving prices but have not all been developed with payer coverage in mind
06
Biosimilars
Expanding patient and provider options while offering financial headroom for innovation, yet still at a nascent phase of commercial development
INDUSTRY NEWS AND ANALYSIS
